Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06187519 · ClinicalTrials.gov registry record · NA

UR+AIMS Gout Wearable Skin Uric Acid Monitor Study

A NA study of Gout, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT06187519 is a NA study of Gout that has completed, run by University of California, Los Angeles. The registered enrollment target is 6 participants, below the 8,888-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06187519, a NA study of Gout, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

15 patients with gout \[10 patients no recent urate-lowering therapy (ULT) and 5 patients on stable urate-lowering therapy (ULT)\] will be invited to participate in a standardized meal at the UCLA Human Nutrition Center and a 7-day community follow-up for the measurement of uric acid (and other metabolites) using our Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch.

Conditions Studied

Interventions

  • DEVICE Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2025-03-10
Est. Completion 2025-09-03
Phase NA

What the Registry Record Tells You About NCT06187519

The ClinicalTrials.gov registry entry for NCT06187519 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,888-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gout appearing as the primary indexed condition, and to 1 intervention - of which Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch is the first listed.

NCT06187519 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06187519 about?

NCT06187519 is a clinical study titled "UR+AIMS Gout Wearable Skin Uric Acid Monitor Study". 15 patients with gout \[10 patients no recent urate-lowering therapy (ULT) and 5 patients on stable urate-lowering therapy (ULT)\] will be invited to participate in a standardized meal at the UCLA Human Nutrition Center and a 7-day community follow-up for the measurement of uric acid (and other meta...

What is the current status of trial NCT06187519?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2025-03-10. Estimated completion is 2025-09-03.

What conditions does trial NCT06187519 study?

This clinical trial studies the following conditions: Gout.

What interventions are being tested in trial NCT06187519?

The interventions under investigation include: Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch (DEVICE).

Who is sponsoring clinical trial NCT06187519?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06187519 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gout

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.